Evidence map›Paper›PMID 39394483›Full record

ArticleNature biotechnology2025

A community effort to optimize sequence-based deep learning models of gene regulation.

Abdul Muntakim Rafi, Daria Nogina, Dmitry Penzar, Dohoon Lee, Danyeong Lee, Nayeon Kim, Sangyeup Kim, Dohyeon Kim, Yeojin Shin, Il-Youp Kwak and 16 more

Abstract read
In one paragraph

Article in Nature biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Genome evolution through polyploidy: Enhancing plant stress resilience in agriculture.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Abdul Muntakim RafiUniversity of British Columbia, Vancouver, British Columbia, Canada. rafi11@student.ubc.ca.ORCID http://orcid.org/0000-0002-0387-5430
Daria NoginaFaculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow, Russia.ORCID http://orcid.org/0000-0002-0593-2726
Dmitry PenzarVavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, Russia.
Dohoon LeeSeoul National University, Seoul, South Korea.ORCID http://orcid.org/0000-0003-2163-5489
Danyeong LeeSeoul National University, Seoul, South Korea.
Nayeon KimSeoul National University, Seoul, South Korea.
Sangyeup KimSeoul National University, Seoul, South Korea.
Dohyeon KimSeoul National University, Seoul, South Korea.
Yeojin ShinSeoul National University, Seoul, South Korea.
Il-Youp KwakChung-Ang University, Seoul, South Korea.ORCID http://orcid.org/0000-0002-7117-7669
Georgy MeshcheryakovInstitute of Protein Research, Russian Academy of Sciences, Pushchino, Russia.
Andrey LandoYandex, Moscow, Russia.
Arsenii ZinkevichFaculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow, Russia.ORCID http://orcid.org/0000-0001-9450-4629
Byeong-Chan KimChung-Ang University, Seoul, South Korea.
Juhyun LeeChung-Ang University, Seoul, South Korea.
Taein KangChung-Ang University, Seoul, South Korea.
Eeshit Dhaval VaishnavBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-3720-8051
Payman YadollahpourBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Random Promoter DREAM Challenge Consortium
Sun KimSeoul National University, Seoul, South Korea.
Jake AlbrechtSage Bionetworks, Seattle, WA, USA.
Aviv RegevBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-3293-3158
Wuming GongUniversity of Minnesota, Minneapolis, MN, USA.ORCID http://orcid.org/0000-0002-3147-4028
Ivan V KulakovskiyVavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, Russia.ORCID http://orcid.org/0000-0002-6554-8128
Pablo MeyerHealth Care and Life Sciences, IBM Research, New York, NY, USA.ORCID http://orcid.org/0000-0001-5281-4661
Carl G de BoerUniversity of British Columbia, Vancouver, British Columbia, Canada. carl.deboer@ubc.ca.ORCID http://orcid.org/0000-0001-8935-5921

Funding

Developing Novel Deep-Learning Based Methods for Deciphering Non-Coding Gene Regulatory CodeR01LM013722 · NLM · STATE UNIVERSITY NEW YORK STONY BROOK · PI RAMANA V DAVULURI · 2021 to 2026
$2.0M
Learning the rules of enhancer activity to understand non-coding genetic variation in autoimmune diseaseK99HG009920 · NHGRI · BROAD INSTITUTE, INC. · PI DE BOER, CARL · 2018 to 2019
$211k
NHGRI NIH HHS K99 HG009920NLM NIH HHS R01 LM013722
6 · The paper itself

Abstract

A systematic evaluation of how model architectures and training strategies impact genomics model performance is needed. To address this gap, we held a DREAM Challenge where competitors trained models on a dataset of millions of random promoter DNA sequences and corresponding expression levels, experimentally determined in yeast. For a robust evaluation of the models, we designed a comprehensive suite of benchmarks encompassing various sequence types. All top-performing models used neural networks but diverged in architectures and training strategies. To dissect how architectural and training choices impact performance, we developed the Prix Fixe framework to divide models into modular building blocks. We tested all possible combinations for the top three models, further improving their performance. The DREAM Challenge models not only achieved state-of-the-art results on our comprehensive yeast dataset but also consistently surpassed existing benchmarks on Drosophila and human genomic datasets, demonstrating the progress that can be driven by gold-standard genomics datasets.

Indexed as

Deep LearningGene Expression RegulationModels, GeneticAnimalsDrosophilaGenomicsHumansNeural Networks, ComputerPromoter Regions, GeneticSaccharomyces cerevisiae

Identifiers

PMID39394483
PMCPMC12339383

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.